Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States.
Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Cell Immunol. 2021 Jan;359:104244. doi: 10.1016/j.cellimm.2020.104244. Epub 2020 Nov 13.
Human Vγ9Vδ2 T cells respond to several diverse pathogens by sensing microbial cholesterol intermediates. Unlike CD4 T cells, they are poised for rapid Th1-like responses even before birth, which allows them to play a key role in the first line of defense against pathogens in early life. However, their regulation and functional maturation during infancy (in particular the acquisition of cytotoxic potential) remain understudied. We thus characterized their responses to cholesterol intermediates and Bacille Calmette-Guérin in a cohort of African neonates and 12-month-old infants. Infant Vδ2 lymphocytes exhibited intermediate or adult-like expression of markers associated with differentiation or function, intermediate proliferative responses, and adult-like cytotoxic potential. The enhancement of Vδ2 cell cytotoxic potential coincided with decreasing PD-1 and increasing NKG2A expression. Our results are consistent with the hypothesis that switching from a PD-1 to a NKG2A phenotype during infancy indicates a shift in mechanisms regulating Vδ2 T cell function.
人类 Vγ9Vδ2 T 细胞通过感知微生物胆固醇中间产物来应对多种不同的病原体。与 CD4 T 细胞不同,它们甚至在出生前就已经准备好快速产生 Th1 样反应,这使它们能够在生命早期对抗病原体的第一道防线中发挥关键作用。然而,它们在婴儿期(特别是获得细胞毒性潜能)的调节和功能成熟仍未得到充分研究。因此,我们在一个非洲新生儿和 12 个月大婴儿的队列中研究了它们对胆固醇中间产物和卡介苗的反应。婴儿 Vδ2 淋巴细胞表现出与分化或功能相关的标志物的中间或成人样表达、中间增殖反应和成人样细胞毒性潜能。Vδ2 细胞细胞毒性潜能的增强与 PD-1 的减少和 NKG2A 表达的增加同时发生。我们的结果与以下假设一致,即在婴儿期从 PD-1 表型向 NKG2A 表型的转变表明调节 Vδ2 T 细胞功能的机制发生了转变。